Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program

about

Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program

Item

http://www.wikidata.org/entity/Q58738440

description

scientific article published on 14 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Improved Treatment Engagement ...... d in the COACH Support Program

@en

Improved Treatment Engagement ...... d in the COACH Support Program

@nl

type

Item

label

Improved Treatment Engagement ...... d in the COACH Support Program

@en

Improved Treatment Engagement ...... d in the COACH Support Program

@nl

prefLabel

Improved Treatment Engagement ...... d in the COACH Support Program

@en

Improved Treatment Engagement ...... d in the COACH Support Program

@nl

P1476

Improved Treatment Engagement ...... d in the COACH Support Program

@en

P2093

Jasvinder Gill

http://www.w3.org/2001/XMLSchema#string

Jodi Strong

http://www.w3.org/2001/XMLSchema#string

Timothy Reid

http://www.w3.org/2001/XMLSchema#string

Tony Horn

http://www.w3.org/2001/XMLSchema#string

William H Polonsky

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Diabetes nurse case management: Improving glucose control: 10 years of quality improvement follow-up data.

Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial.

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month exten

Implementing community-based diabetes programs: the scripps whittier diabetes institute experience.

The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial.

Behavioral Programs for Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis.

P2888

s13300-018-0501-6

P304

2143-2153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S13300-018-0501-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Goldman

P577

2018-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30218432

http://www.w3.org/2001/XMLSchema#string

P921

Insulin

P932

6167296

http://www.w3.org/2001/XMLSchema#string